Detalles de la búsqueda
1.
Perioperative Nivolumab in Resectable Lung Cancer.
N Engl J Med
; 390(19): 1756-1769, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749033
2.
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Lancet Oncol
; 24(9): 1002-1017, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657460
3.
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
Lancet Oncol
; 23(10): 1274-1286, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108662
4.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 22(1): 51-65, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33285097
5.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
N Engl J Med
; 379(23): 2220-2229, 2018 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280641
6.
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Lancet
; 394(10212): 1929-1939, 2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31590988
7.
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
N Engl J Med
; 376(25): 2415-2426, 2017 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28636851
8.
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
N Engl J Med
; 373(2): 123-35, 2015 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26028407
9.
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(6): 822-835, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27132212
10.
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(1): 59-68, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24331154
11.
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.
Clin Cancer Res
; 30(4): 824-835, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801329
12.
Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer.
Lancet Reg Health Eur
; 38: 100839, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38476751
13.
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; 42(7): 808-820, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042525
14.
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries.
Lancet Reg Health Eur
; 38: 100838, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38476742
15.
Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer.
J Cancer Res Clin Oncol
; 149(19): 17123-17131, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37768380
16.
Worse Prognosis in the Symptomatic Patients With Lung Cancer - Czech Multicentric Study.
Cancer Diagn Progn
; 2(2): 167-172, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35399169
17.
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report.
JTO Clin Res Rep
; 3(6): 100330, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35719865
18.
An ocular lesion of unknown aetiology.
Breathe (Sheff)
; 17(2): 200164, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34295416
19.
Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry.
Anticancer Res
; 41(11): 5549-5556, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34732425
20.
Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial.
Cancer Treat Res Commun
; 28: 100427, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34284344